Literature DB >> 4009789

mRNA sequence of three respiratory syncytial virus genes encoding two nonstructural proteins and a 22K structural protein.

N Elango, M Satake, S Venkatesan.   

Abstract

An mRNA sequence of two human respiratory syncytial viral nonstructural protein genes and of a gene for a 22,000-molecular-weight (22K) protein was obtained by cDNA cloning and DNA sequencing. Sequences corresponding to the 5' ends of the respective transcripts were deduced directly by primer extension and dideoxy nucleotide sequencing of the mRNAs. The availability of a bicistronic clone (pRSC6) confirmed the gene order for this portion of the genome. Contrary to other unsegmented negative-stranded RNA viruses, a 19-nucleotide intercistronic sequence was present between the NS1 and NS2 genes. The translation of cloned viral sequences in the bicistronic and monocistronic clones (pRSNS1 and pRSNS2) revealed two moderately hydrophobic proteins of 15,568 and 14,703 daltons. Their similarity in molecular size explained our earlier inability to resolve these proteins. A DNA sequence of an additional recombinant plasmid (pRSA2) revealed a long open reading frame encoding a 22,156-dalton protein containing 194 amino acids. It was relatively basic and moderately hydrophobic. A protein of this size was readily translated in vitro from a viral mRNA hybrid selected by this plasmid and corresponded to an unglycosylated 22K protein seen in purified extracellular virus but not associated with detergent- and salt-resistant cores. A second open reading frame of 90 amino acids partially overlapping with the C terminus of the 22K protein was also present within this sequence. This was reminiscent of the viral matrix protein gene which was previously shown by us to contain two overlapping reading frames. The finding of three additional viral transcripts encoding at least three identifiable proteins in human respiratory syncytial virus was a novel departure from the usual genetic organization of paramyxoviruses. The 5' ends of all three transcripts had a 5'NGGGCAAAU sequence that is common to all viral transcripts analyzed so far. Although there was no obvious homology immediately upstream of the polyadenylate tail, an AGUUA (AGUAA in the case of NS2) was present between 1 and 4 nucleotides upstream of the polyadenylate end of NS1 and 22K protein mRNAs.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4009789      PMCID: PMC254903     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  An improved method for detecting foreign DNA in plasmids of Escherichia coli.

Authors:  R E Thayer
Journal:  Anal Biochem       Date:  1979-09-15       Impact factor: 3.365

2.  The synthesis of sendai virus polypeptides in infected cells.

Authors:  R A Lamb; B W Mahy; P W Choppin
Journal:  Virology       Date:  1976-01       Impact factor: 3.616

3.  RNA molecular weight determinations by gel electrophoresis under denaturing conditions, a critical reexamination.

Authors:  H Lehrach; D Diamond; J M Wozney; H Boedtker
Journal:  Biochemistry       Date:  1977-10-18       Impact factor: 3.162

4.  Respiratory syncytial virus polypeptides: their location in the virion.

Authors:  M Peeples; S Levine
Journal:  Virology       Date:  1979-05       Impact factor: 3.616

5.  Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.

Authors:  P S Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

6.  Computer analysis of nucleic acids and proteins.

Authors:  C L Queen; L J Korn
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

7.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

8.  5' and 3' terminal nucleotide sequences of the RNA genome segments of influenza virus.

Authors:  J S Robertson
Journal:  Nucleic Acids Res       Date:  1979-08-24       Impact factor: 16.971

9.  Polycistronic vesicular stomatitis virus RNA transcripts.

Authors:  R C Herman; M Schubert; J D Keene; R A Lazzarini
Journal:  Proc Natl Acad Sci U S A       Date:  1980-08       Impact factor: 11.205

10.  Complete nucleotide sequence of an influenza virus haemagglutinin gene from cloned DNA.

Authors:  A G Porter; C Barber; N H Carey; R A Hallewell; G Threlfall; J S Emtage
Journal:  Nature       Date:  1979-11-29       Impact factor: 49.962

View more
  6 in total

1.  Expression of the ORF-2 protein of the human respiratory syncytial virus M2 gene is initiated by a ribosomal termination-dependent reinitiation mechanism.

Authors:  G Ahmadian; J S Randhawa; A J Easton
Journal:  EMBO J       Date:  2000-06-01       Impact factor: 11.598

2.  Transcription of human respiratory syncytial virus genome RNA in vitro: requirement of cellular factor(s).

Authors:  S Barik
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

3.  Gene overlap and site-specific attenuation of transcription of the viral polymerase L gene of human respiratory syncytial virus.

Authors:  P L Collins; R A Olmsted; M K Spriggs; P R Johnson; A J Buckler-White
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

4.  Respiratory syncytial virus envelope glycoprotein (G) has a novel structure.

Authors:  M Satake; J E Coligan; N Elango; E Norrby; S Venkatesan
Journal:  Nucleic Acids Res       Date:  1985-11-11       Impact factor: 16.971

5.  Nucleotide sequences for the gene junctions of human respiratory syncytial virus reveal distinctive features of intergenic structure and gene order.

Authors:  P L Collins; L E Dickens; A Buckler-White; R A Olmsted; M K Spriggs; E Camargo; K V Coelingh
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

6.  Walking along the rabies genome: is the large G-L intergenic region a remnant gene?

Authors:  N Tordo; O Poch; A Ermine; G Keith; F Rougeon
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.